3
Announcements
Trials
Browse
Landscape
Status
Recruiting
3
Not yet recruiting
2
Withdrawn
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
1
Adenocarcinoma
1
Interventions
pembrolizumab
4
Radiotherapy
4
Radiation
4
ALT-803
4
fludarabine
3
Prednisone
3
Etoposide
3
Cytarabine
3
Cyclophosphamide
3
Cisplatin
3
Biopsy
3
sacituzumab govitecan
2
daratumumab
2
atezolizumab
2
Vincristine
2
Temozolomide
2
Surveys and Questionnaires
2
Specimen Handling
2
Nivolumab
2
Magnetic Resonance Spectroscopy
2
Lenalidomide
2
Irinotecan
2
Gemcitabine
2
Doxorubicin
2
Blood Specimen Collection
2
Bevacizumab
2
Androgen Antagonists
2
130-nm albumin-bound paclitaxel
2
zimberelimab
1
vocimagene amiretrorepvec
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Transurethral Resection of Prostate
×
90 days
×
Clear all
NCT07237399
2026-05-13
TA-P-OLIM
University Hospital, Ghent
Withdrawn